Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Longitudinal serum proteomic and metabolomic tracking of chronic hepatitis B during tenofovir disoproxil fumarate Therapy

ABSTRACT: Longitudinal serum proteomic and metabolomic tracking of chronic hepatitis B during tenofovir disoproxil fumarate Therapy

ORGANISM(S): Homo Sapiens

SUBMITTER: Xialin Pei

PROVIDER: PXD073035 | iProX | Tue Jan 13 00:00:00 GMT 2026

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells

Project description:The objective of this study is to identify immunological mechanisms that contribute to normalization of liver inflammation in chronic hepatitis B (CHB) patients starting the antiviral nucleoside analogue, Tenofovir alafenamide (TAF).

2022-12-01 | GSE216314 | GEO

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells

Project description:Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells

| PRJNA892977 | ENA

Up-regulated aldo-ketoreductase1B10 in chronic hepatitis C: Association with serum alpha-fetoprotein and hepatocellular carcinoma

Project description:We attempted to identify a specific gene expression signature by performing microarray analysis on the livers of patients with chronic hepatitis C and AFP elevation. Distinct hepatic gene expression patterns were demonstrated between patients with elevated AFP (≥10ng/mL) and normal AFP (<10ng/mL). Among the 30,150 valid genes, 627 were identified as differentially expressed genes with a minimal fold change of 2.0. Using these 627 genes, PCA and HCA were used to successfully distinguish samples according to their AFP status. Of the 627 differently expressed genes, AKR1B10 was most abundantly expressed in patients with elevated AFP. AKR1B10 expression was validated by Real-time RT-PCR and immunohistochemical study. Furthermore, a proportional correlation between AKR1B10 expression and serum AFP was demonstrated by regression analysis. A matched case-control study indicated that AKR1B10 up-regulation was an independent risk factor for HCC development. Liver tissues samples from 48 chronic hepatitis C patients were stratified by their serum AFP levels and analyzed for gene expression profiles. AKR1B10 was up-regulated in patients with chronic hepatitis C in association with serum AFP, and was an independent risk factor for HCC development.

2014-09-15 | E-GEOD-32221 | biostudies-arrayexpress

Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection

Project description:Most individuals exposed to hepatitis C virus (HCV) become persistently infected while a minority spontaneously eliminate the virus. Although early immune events influence infection outcome, the cellular composition, molecular effectors, and timeframe of the host response active shortly after viral exposure remain incompletely understood. Employing specimens collected from people who inject drugs (PWID) with high risk of HCV exposure, we utilized RNA-Seq to characterize immune function in peripheral blood before, during, and after acute HCV infection resulting in spontaneous resolution. Our results provide a detailed description of innate immune programs active in peripheral blood during acute HCV infection, which include prominent type I interferon and inflammatory signatures. Innate immune gene expression rapidly returns to pre-infection levels upon viral clearance. This innate response coincides with a decrease in B cell transcriptional signatures. These results represent the first longitudinal transcriptomic characterization of human immune function in acute HCV infection and identify several dynamically regulated features of the complex response to natural HCV exposure.

2018-08-29 | GSE119117 | GEO

Serum EV proteome target analysis of liver fibrosis in chronic hepatitis C patients

Project description:Serum EV proteome target analysis of liver fibrosis in chronic hepatitis C patients was performed.

2023-01-27 | PXD031289 | JPOST Repository

Distinct serum microRNA profiles in patients with active autoimmune hepatitis

Project description:Serum microRNAs are useful for the early diagnosis and management of autoimmune hepatitis

2022-04-27 | GSE140249 | GEO

Transcriptomic analysis of the woodchuck model of chronic hepatitis B

Project description:This SuperSeries is composed of the following subset Series: GSE36533: Transcriptomic analysis of the woodchuck model of chronic hepatitis B: Liver gene expression in uninfected, resolved and chronically infected woodchucks GSE36541: Transcriptomic analysis of the woodchuck model of chronic hepatitis B: Kidney gene expression in uninfected, resolved and chronically infected woodchucks GSE36544: Transcriptomic analysis of the woodchuck model of chronic hepatitis B: Spleen gene expression in uninfected, resolved and chronically infected woodchucks GSE36545: Transcriptomic analysis of the woodchuck model of chronic hepatitis B: Liver gene expression in tumor and non-tumor samples from chronically infected woodchucks Refer to individual Series

2012-04-10 | E-GEOD-36250 | biostudies-arrayexpress

Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection

Project description:Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection

| PRJNA488222 | ENA

The serum proteomics tracking of HBsAg low-level nucleoside analogues treatment of chronic hepatitis B combined with Pegylated Interferon therapy

Project description:Chronic hepatitis B (CHB) remains a major public health problem worldwide. Combined use of nucleoside analogues (NAs) and polyethylene glycolated interferon (PEG-IFNα) can rapidly reduce hepatitis B surface antigen (HBsAg) levels and lead to clinical cure in some advantaged populations. However, the specific molecular mechanisms by which NAs in combination with interferon therapy achieve rapid HBsAg reduction are unknown. To investigate the biomolecular differences associated with combination therapy, we analysed serum protein mass spectra from 25 patients with chronic hepatitis B who experienced a rapid reduction in HBsAg levels after combination therapy. Analyses were performed using data-independent acquisition (DIA)-based liquid chromatography-mass spectrometry before treatment, at week 12 of treatment, and at week 24 of treatment. A total of 3174 proteins were identified in our study. Among these proteins, 54 and 154 dysregulated proteins were detected at week 12 and 24 of treatment, respectively, compared with the pretreatment period.

2025-01-15 | PXD059801 |

stem cell therapy of murine acute hepatitis

Project description:Gene expression profiles of the liver and hepatic inflammatory cells in murine concanavalin A-induced acute hepatitis models by treatment with adipose tissue derived stem cells

2012-10-11 | GSE41465 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data